Displaying 25 - 28 of 28

Display:

12 24 48

Immune-Mediated and Cholestatic Diseases

7

CymaBay Therapeutics: Taking Aim at Primary Biliary Cholangitis - EASL Congress 2024

View

Immune-Mediated and Cholestatic Diseases

7

CymaBay Therapeutics: Taking Aim at Primary Biliary Cholangitis - EASL Congress 2024

View

Immune-Mediated and Cholestatic Diseases

7

CymaBay Therapeutics: Taking Aim at Primary Biliary Cholangitis - EASL Congress 2024

View

Immune-Mediated and Cholestatic Diseases

7

CymaBay Therapeutics: Taking Aim at Primary Biliary Cholangitis - EASL Congress 2024

View

Displaying 25 - 28 of 28

Display:

12 24 48